ATAI ATAI Life Sciences NV

  1. Stocks
  2. Healthcare
  3. NASDAQ: ATAI

Price (delayed)

$7.25

Market cap

$2.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.77

Enterprise value

$2.52B

?
Relative Growth: Rel. Growth: 52
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 15

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity. ATA Creativity Global offers a wide range of education ...

Highlights
ATAI Life Sciences's revenue has surged by 94% YoY and by 28% QoQ
The company's gross profit has surged by 94% YoY and by 28% QoQ
ATAI's quick ratio has surged by 110% year-on-year but it is down by 14% since the previous quarter
The equity has increased by 23% year-on-year but it has declined by 11% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.atai.life
Peers: FC UTI GHC

Key stats

What are the main financial stats of ATAI

ATAI stock price

How has the ATAI Life Sciences stock price performed over time
Intraday
0.28%
1 week
0.97%
1 month
45.88%
1 year
79.01%
YTD
77.26%
QTD
37.57%

Financial performance

How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$4.47M
Gross profit
$4.47M
Operating income
-$653.86M
Net income
-$668.19M
Gross margin
100%
Net margin
-14,938.4%
The net margin has dropped by 189% year-on-year but it is up by 21% since the previous quarter
ATAI Life Sciences's revenue has surged by 94% YoY and by 28% QoQ
The company's gross profit has surged by 94% YoY and by 28% QoQ
ATAI Life Sciences's operating margin has increased by 20% from the previous quarter

Price vs fundamentals

How does ATAI's price correlate with its fundamentals

Growth

What is ATAI Life Sciences's growth rate over time

Valuation

What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
15.13
P/S
584.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
563.79
The P/B is 94% more than the last 4 quarters average of 7.8
The equity has increased by 23% year-on-year but it has declined by 11% since the previous quarter
ATAI Life Sciences's revenue has surged by 94% YoY and by 28% QoQ
ATAI's P/S is 68% above its last 4 quarters average of 348.9 but 14% below its 5-year quarterly average of 679.6

Efficiency

How efficient is ATAI Life Sciences business performance
ATAI's ROS has dropped by 196% year-on-year but it is up by 21% since the previous quarter
The company's return on invested capital fell by 7% QoQ
ATAI's ROA is up by 6% since the previous quarter
The company's return on equity rose by 3.6% QoQ

Dividends

What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATAI.

Financial health

How did ATAI Life Sciences financials performed over time
ATAI's total assets is 200% more than its total liabilities
The current ratio has soared by 113% YoY but it has contracted by 14% from the previous quarter
ATAI's quick ratio has surged by 110% year-on-year but it is down by 14% since the previous quarter
The debt is 99% smaller than the equity
The company's debt to equity has shrunk by 83% YoY
The debt has dropped by 80% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.